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Abstract 
The thesis details the development of a decarboxylative synthesis of aryl 
ethers using a relatively new Iron catalyst and a  novel decarboxylative coupling 
of coumarins catalyzed by palladium. 
Aryl allyl carbonates underwent facile decarboxylative coupling  
presence of a new iron catalyst. The allylation is found to be regios lective rather 
than regiospecific. This suggests that the allylation proceeds through π-allyl iron 
intermediates in contrast to related allylations of carbon nucleophil s t at proceed 
via σ-allyl complexes. The reason we looked at iron as a catalyst was o offset the 
cost of expensive palladium catalyst usually used in these types of reactions. 
  The second project involved allyl esters of 3-carboxylcoumarins, which 
underwent facile decarboxylative coupling at just 25−50 °C in moderate to good 
yields. This represents the first extension of decarboxylative C−C bond-forming 
reactions to the coupling of aromatics with sp3-hybridized electrophiles. Finally, 
the same concept can be applied to the sp2−sp3 couplings of pyrones and 
thiocoumarins. A variety of biologically important heteroaromatics can be readily 
functionalized without the need for strong bases or stoichiometric organometallics 
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1.1 Allylic Etherification: 
Palladium and Ruthenium-catalyzed allylation reactions have attracted a 
lot of attention in the last three decades. The Tsuji-Trost allylation reaction has 
been extensively explored and has been a source of great inspiration to many 
research groups since its discovery in 1965. 1,2 
The general reaction mechanism for the Tsuji-Trost reaction is shown in 
Scheme 1. The first step in the reaction is co-ordination of the Pd(0) catalyst to 
the double bond of the allylic substrate 1a. This is followed by the nucleophilic 
substitution of the leaving group (X) by the nucleophilic Pd center. As a result, 
the metal goes up by two oxidation states and thus this process is called an 
oxidative addition. The nucleophilic displacement occurs using the backbonding 
d-orbitals of Pd in order to generate a π- llylpalladium complex 1c. This complex 
is electrophilic in nature, with the metal centre bearing most of the positive charge 
in case of π-allylpalladium complexes, and the three carbons of the allyl fragment 
share the positive charge equally amongst themselves. This complex again 
undergoes nucleophlic displacement by the attack of an external nucleophile in 
order to generate the allylated product 1e. 
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Scheme 1: Tsuji-Trost allylation reaction 
 
Depending on the nature of the nucleophile, Trost proposed two different 
mechanisms3 as shown in Scheme 2. In case of hard nucleophiles, the metal 
center of the π-allylpalladium complex is attacked by the nucleophile, followed 
by reductive elimination to give the product 2b with overall inversion of 
stereochemistry. Whereas, in case of soft nucleophiles, the π-allyl unit is directly 
attacked in a SN2 displacement which generates the product 2c with retention of 
R X+Nuc
Pd(0)Ln
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configuration by a double inversion mechanism. An important point to be noted
here is that majority of the charge is borne on the metal centre itself, and the 
incoming nucleophile almost always chooses to attack the less hindered allyl 
carbon center purely out of steric constraints. 











In case of Ru, the π-allylruthenium species 2b has a positive charge on the 
metal centre. But Ru, unlike Pd, does not bear the majority of charge. Inst ad the 
charge is distributed it to the terminal allyl carbons and the most substituted 
carbon of the allyl fragment ends up bearing majority of the positive charge. 
Thus, the incoming nucleophile attacks the more substituted carbon and generates 
the allylated product 3c with branched selectivity. The regioselectivity is 












soft Nuc : CH2(CO2R)2 etc
Nuc
2b 2c
hard Nuc : RMgBr, RLi etc
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different stereochemical outcomes while using Pd and Ru centered catalysts. Tsuji 
reported the first ruthenium catalyzed allylic alkylation in 1985 as illustrated in 
Scheme 3.4 The branched product 3d was favored when RuH2(PPh3)4 or a 
combination of RhH(PPh3)4 with n-butyl phosphine were used as catalyst. Not 
surprisingly, the palladium catalyst favored the formation of the linear product 3c.  
Scheme 3: Ruthenium catalysis 
 
However, a major drawback with some Pd-catalyzed allylations is 
competing β-hydride elimination. In presence of β-hydrogens on the allyl 
fragment, β-hydride elimination occurs readily, giving a diene and Pd(0). Another 
major drawback associated with Pd and Ru-catalyzed reactions is the cost of the 
metal. Both Pd and Ru are very expensive metals, and it would be of gr at use to 
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We were particularly interested in the formation of allylic ethers which could 
readily undergo a Claisen rearrangement in order to access prenylated phenols. In 
the literature, no methods exist currently that generate prenylat d phenols directly 
from allylic carbonates. Nicolaou used a 3 step procedure, outlined in Scheme 5, 
to access these structures in synthesis of several natural products like 
lateriflorone, 1-O-methyllateriferone and artochamins F, H, I and J.5-8 The yield 
over these three steps is around 50-55%. 




OMe 1) DBU, Cat CUCl2, H
OCOCF3
2) H2, Lindlar Catalyst
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 There is another report in literature by Kawamura,9 where 
traditional cross coupling methods have been used in order to access prenylated 
phenols (scheme 6). This particular route is quite lengthy, low yielding, and has a 
small substrate scope. 
Scheme 6: Cross-coupling methods 
More recently, Hartwig and Evans group have come up with methods for 
forming substituted allylic ethers using expensive iridium and rhodium based 
catalysts (scheme 7).10, 11 
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We proposed that a short concise route to access C-allylated phenols via 
an allylic etherification followed by a tandem aromatic Claisen reaction would be 
beneficial (Scheme 8). 
Scheme 8: Synthetic strategy 
 
In order to get the desired phenol, we would have to generate an allylic
ether in situ with a specific regioselectivity. To access that particular regioisomer 
8a, the incoming nucleophile after the π-allyl formation, would have to attack the 
more substituted carbon. This inherently requires two important things. Firstly, no 
β-hydride elimination should occur after π-allyl formation, and secondly, the π-
allyl metal complex formed should be unsymmetrical in nature. After the 
formation of 8b, we envisioned a tandem claisen rearrangement to access the 
phenol 8c. A thorough literature search led us to conclude that two metals th t 
were not reported in literature could facilitate this type of a process. In the 
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1.2 Decarboxylative sp2-sp3 coupling: 
In recent years, significant effort has been devoted to the development of 
decarboxylative couplings that allow C—C bond forming cross-couplings without 
the need for preformed organometallics.12-24 In avoiding the need for preformed 
organometallic reagents, decarboxylative couplings often avoid the use of highly
basic reaction conditions12 and the production of stoichiometric metal waste. Our 
group has been actively working on Pd and Ru catalyzed decarboxylative C—C 
bond forming reactions. Previously we have worked extensively on coupling sp3 
and sp hybridized nucleophiles with π-allylpalladium complexes.13, 14 In case of 
sp3-hybridized nucleophiles (Scheme 9), stabilization by an electron withdrawing 
group like an ester, ketone, nitro, cyano or sulfone is necessary, so as to afford a 
C—C coupling.12-15 





In case of sp-hybridized nucleophiles,13 π-allylpalladium-acetylide 
intermediates were accessed after decarboxylation of allyl propiolates followed by 
reductive elimination to give 1,4-enyne products (Scheme 10). 
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However, coupling of sp2-hybridized nucleophiles has been found to be 
particularly challenging, due to the fact that decarboxylation of a sp2-hybridized 
carboxylic acids is energetically unfavorable.16-19 One remarkable example is the 
decarboxylative biaryl synthesis developed by Gooßen (Scheme 11).20, 21  For all 
its potential utility, such sp2-sp2 couplings require decarboxylative metalation of 
sp2-hybridized carbons, a relatively high energy process that utilizes copper co-
catalysts at 120-170 oC. A similar, co-catalyst free, decarboxylative coupling of 
heteroaromatics was also reported to occur at 150 oC.22 
Scheme 11: Biaryl coupling 
 
Another notable example is the coupling of aryl carboxylic acids with
styrenes in presence of Pd(II) and silver carbonate (Scheme 12). Major drawbacks 
of this reaction include the need to be heated at 120 oC and the requirement of 
three equivalents of expensive silver carbonate, rendering this process rather 
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Scheme 12: Aryl acid coupling with alkenes 
 
 Thus, these promising reactions could still benefit from the development 
of more mild conditions for the cross-coupling.  In addition, the decarboxylative 
coupling of aromatics and heteroaromatics has not been extended to sp2-sp3
couplings, which would dramatically expand the structures that can be 
synthesized by decarboxylative arylation. Our initial goal was to perform a 
decarboxylative sp2-sp3 coupling at mild to moderate temperatures. For this 
purpose, we investigated several molecular systems. In looking for scaffolds on 
which to develop decarboxylative sp2-sp3 couplings, we eventually found 
coumarins as suitable substrates for our methodology. 
Coumarins are privileged structures in biological chemistry and numerous 
pharmaceuticals are based on development of this basic scaffold (Scheme 13).25-28 
In principle, a decarboxylative allylation of coumarins provides access to 
compounds like warfarin (13a) and also allow the synthesis of a wide variety of 3-
alkylcoumarins for biological screening. We were able to generate 3-alkyl 
coumarins with great ease, and filled a gap in literature with regards to the 
synthesis of these compounds.  
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Traditional cross coupling methods can be applied readily to 3-
bromocoumarin so as to access variously substituted 3-alkyl coumarins.29 As 
shown in Scheme 14, 3-bromocoumarin undergoes a Heck coupling to give 3-
vinylsubstituted coumarin 14a. 3-bromocoumarin can also be coupled with aryl 
boronic acids in a Suzuki reaction to give us 3-arylsubstituted coumarin 14b. 
Lastly a Sonogashira coupling will yield acetylenic substitution at the 3 position 
to give 14c.29 While these standard cross-couplings are useful, a mild 
decarboxylative method for analogous couplings would have significant 
advantages like avoiding preformed organometallic reagents, basic reaction 





















13a anticoagulant 13b antitumor 13c anti-TNF
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Scheme 14: Cross-coupling reactions of 3-bromocoumarin 
 
Ahluwalia prepapred 3-alkyl coumarins utilizing a Claisen rearrangement 
followed by a deoxygenation (Scheme 15).30 In their route, they start with 4-
hydroxycoumarin 15a and form the allyl ether 15b by reacting the former with 
allyl bromide in presence of a base. Heating 15b in presence of acetic anhydride 
gives product 15c as the Claisen rearranged product with an acetyl group. This is 
followed by a deprotection to give the free alcohol 15d. Reaction of 15d with 
tosyl chloride gives the tosylated 15e. Treatment of 15e with Zn/HCl in presence 
of water and ethanol gives product 15f as the 3 alkyl coumarin with no 
substitution at the 4 position. The route gives the final product in very low 
yields.30 As can be seen, in order to install the allyl functionality at the 3 position, 
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removed. These steps can be avoided if a direct coupling method was avail ble to 
access 3-allyl coumarins.  
Scheme 15: Claisen route to 3-allyl coumarins 
 
Another way to access 3-alkyl coumarins is by forming the coumarin core 
from a substrate that already contains the appropriate substitution (Scheme 16).31 
For example, the precursor to cyclization 16c, is formed by condensing 2-hydroxy 
benzaldehyde 16a with the wittig salt 16b. The wittig salt is synthesized by 
simply allylating commercially available ethyl (triphenylphosphoranylidene) 
acetate. The diene 16c readily undergoes cyclization with the elimination of 
ethanol to give 3-allyl coumarin 16d. 















































16a 16b 16c 16d
16e
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As may be expected given the above illustrations, 3-alkyl coumarins have 
not been thoroughly utilized due to the low yielding multiple step synthetic routes 
required for their formation. In the following chapters we describe our 
methodology development and the significant advantages that our methodology 
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2.1 Catalyst Selection 
Our group was particularly interested in decarboxylative allylic 
etherification. As discussed earlier, decarboxylative allylation reactions are a 
powerful method for the allylation of a wide variety of nucleophiles under neutral 
conditions. A remaining issue with decarboxylative allylations is their reliance on 
relatively expensive platinum group metals.1 
Figure 1: Cost comparision of metal catalysts 
 
Decarboxylative allylation has been reported to occur with Pd,2-4 Rh,5 and 
more recently Ru-based catalysts.6-8 A single example of Nickel-catalyzed 
decarboxylative allylation also exists, but the yields and reaction onditions were 
not reported in that paper.5 
The first palladium-catalyzed decarboxylative etherification was report d 
in 1981, and Larock later generalized the transformation into a useful method.9 
Initial attempts at the intermolecular version failed, as they were not able o 
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catalyze the reaction of allyl acetate with phenoxides in presence of palladium 
(scheme 17). An intramolecular variation was reasoned to overcome reluctance of 
the intermolecular displacement. Initial attempts at enantioselective coupling were 
not fruitful (< 23% ee),5 however, these reactions provided the foundation for the 
recent enantioselective Ru-catalyzed decarboxylative etherification.6 




Likewise, we posited that a ruthenium centered catalyst could give us the 
desired regioselectivity for our transformation, but again ruthenium is also a 
relatively expensive metal. In search of a more economical alternative, we 
stumbled upon an anionic iron complex, known as the Hieber anion,10-18 with 
similar activity. We were drawn to the seminal iron-catalyzed allylic alkylations 
of Roustan10 and more recently Plietker.15-18 Roustan et al worked on catalyzing 
alkylations with this anionic iron complex in the early 1980’s. However they were 
operating under an atmosphere of CO which is not desirable. We wanted to avoid 
CO and develop a catalytic process that operates under a more inert gas. 
More recently, Plietker has used phosphine and N-heterocyclic carbene-
modified versions of the Hieber anion to form electrophilic allyl species from 
allylic carbonates.15-18 However, Plietker has not investigated the loss of CO2 
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Thus, we chose to investigate the decarboxylative allylic etherification using this 
iron catalyst. 
 
2.2 The Hieber Anion 
The Hieber anion was discovered some 80 years ago by Walter Hieber. He 
reported the formation of nucleophilic carbonylmetalates from carbonylmetal 
compounds in the presence of hydroxide anions (scheme 18).19-24 This is 
popularly known as the Hieber base reaction, where nucleophilic addition of 
hydroxide to a carbonyl ligand occurs with the subsequent loss of CO2  and 
simultaneous reduction of the metal center. 
Scheme 18: The Hieber base reaction 
 
The application of the Hieber base reaction to iron pentacarbonyl yields to 
the well–known highly nucleophilic [Fe(CO)4]
2- dianion (Hieber anion).25, 26 The 
stoichiometric chemistry of tetracarbonyl ferrate dianion has been extensively 
studied.27, 28 In particular, the seminal contributions of Collman (Collman’s 
reagent) demonstrated the synthetic utility of these anions.29-33 This anion exhibits 
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a high degree of electron density on the metal centre, which makes it a very strong 
nucleophile.29 The dianion is isoelectronic with nickel tetracarbonyl, which has no 
nucleophilicity. Apart from hydroxide, different nucleophiles can be employed in 
this reaction. The use of nitrite as an oxygen centred nucleophile leads to different 
reaction course, in which a CO ligand is exchanged for a NO ligand with 
simultaneous reduction of the metal centre (scheme 19). The resulting ni rosyl 
complex is known as the Hieber anion and is noteworthy as it is more stable and 
less toxic than tetracarbonylferrate. In case carbon centered nucleophiles are used, 
1, 2 addition occurs to give metallaenolates. These can be trapped by strong 
alkylating reagents like Meerwein’s salt to give Fischer-type carbene complexes 
of iron.34-36 
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2.3 Applications of the Hieber Anion 
One of the most exciting developments with the Hieber anion was 
generation of stable π-allyliron complexes from dienes. This was achieved using 
hydridoferrate [HFe(CO)3(NO)] when the sodium salt of the iron complex is 
converted to hydridoferrate by protonation of the sodium salt with acetic or 
trifluoroacetic acid.37-38 Chaudhari et al reported an interesting application of the 
hydridoferrate complex (Scheme 20). They prepared the complex insitu in 
presence of 1,3-butadiene yielding the corresponding π-allyliron complex through 
hydrometallation.39 








The Hieber anion has been used recently in literature by Roustan to access 
the π-allyliron species directly from allylic carbonates. A major drawback of this 
process was the need for a carbon monoxide atmosphere in order to retain 
catalytic activity of the complex. As seen in scheme 20, once the allyl fragment is 
attacked by the Hieber anion, the iron complex exchanges one of the carbon 
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monoxide ligands for the allyl ligand. Hence after the nucleophilic substitution, 
the empty co-ordination site on the iron catalyst needs to be filled up by carbon 
monoxide.  
Scheme 21: Iron complex reactions 
 
More recently Plietker has used this complex to catalyze C—C bond
formation. More specifically, Plietker circumvented the use of a carbon monoxide 
atmosphere by replacing one of the carbon monoxide ligands of NaFe(CO)3(NO)  
with a phosphine ligand. Their group has used phosphine and N-heterocyclic 
carbene-modified versions of the Hieber anion, with a tetrabutyl ammonium 
counterion, to form electrophilic allyl species from allylic carbonates. The 
reaction does not need to be run in a carbon monoxide atmosphere when 
phosphine or N-heterocyclic carbene ligands are used. This is a major advantage 
and makes the catalytic process very convenient. Furthermore, Plietker has also 
used the complex to catalyze the formation of C—S and C—N bonds.40, 41  




















Bu4N[Fe(CO)3NO] (5 mol%) , PPh3 (5 mol%)
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However, Plietker has not investigated the loss of CO2 from such allylic 
carbonates as a method for decarboxylative coupling reactions.  Thus, we chose to 
investigate the decarboxylative allylic etherification using iron catalysts. 
 
2.4 Approach 
To begin, we compared a small variety of catalysts for their ability to 
effect the decarboxylative allylation of phenols (Table 1). Here the qualitative rate 
of decarboxylative allylation, as catalyzed by PPh3-modified Bu4N[Fe(CO)3NO)] 
(1), was compared with those of more standard Pd and Ru catalysts. These studies 
show that the order of reactivity is Pd > Ru > Fe. While the iron catalyst was not 
the most active, iron is over 10,000 times less expensive than either ru nium or 
palladium. Thus, the scope of the iron-catalyzed decarboxylative etherification 
was worthy of further investigation. 
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2.5 Scope 
We started with simple allyl fragments, but various substitution patterns 
on the phenol. Decarboxylation took place at 80 oC in presence of 10 mol% of the 
iron catalyst. We found that triphenylphosphine was the best ligand for our 
reaction. The reactions were stirred in sealed vials for the time specified in Table 
2 until TLC monitoring revealed there was no further increase in the ratio of 
product to starting material.  
Scheme 23: General reaction 
 
In particular, the reaction is effective for nearly any substitution pattern 
about the phenol; even sterically demanding phenolates undergo allylation, albeit 
at a reduced rate.  In addition, allyl ethers of electron rich phenols like 3e undergo 
exclusive O-allylation.  Related palladium-catalyzed allylations of 3,5-
dimethoxyphenol are often plagued by the formation of C-allylated products.42, 43  
Lastly, aryl halides are tolerated.  These functional groups have t e potential to 
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Table 2: Decarboxylative allylation of various substituted phenols 
 
 

























































Reaction conditions: 10 mol% Bu4N[Fe(CO)3NO], 10 mol % PPh3, MTBE solvent, 80
oC
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Next, the regioselectivity of the allylation was investigated (Table 3).  In 
all cases, the cinnamyl carbonates preferentially formed the linear allylic ethers in 
good yield (Scheme 24).  
Scheme 24: Branched and Linear products 
 
Here, one can also see that the reaction is compatible with electron 
withdrawing groups on the phenol like CF3 and CO2Me.  To investigate the 
regiospecificity of the allylation, the product of the reaction of a cinnamyl 
carbonate was compare to that derived from a 1-phenylallyl carbon te.  As can be 
seen, both substrates provided the linear product exclusively as judged by 1H 
NMR spectroscopy.  Thus, the reaction with aryl-substituted allylic carbonates is 
regioselective. 
Scheme 25: Substituted allyl fragment 
 
Next, we investigated the coupling of crotyl alcohol, which provided the 
branched allylation product with moderate regiocontrol and high yield (entry 10).  
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selectively (entry 9).  While the regiochemical outcome slightly depends on the 
regiochemistry of the starting allyl ester, the reaction is not strongly re iospecific.  
































































































Reaction conditions: 10 mol% Bu4N[Fe(CO)3NO], 10 mol % PPh3, MTBE solvent, 80
oC
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Thus, the decarboxylative etherfication is best referred to as a 
regioselective reaction.  This is an interesting observation since Xu,12, 13 and more 
recently Plietker, have shown that the analogous iron-catalyzed allylation of 
carbon nucleophiles is a regiospecific process, with nucleophilic attack occurring 
to preserve the regiochemistry present in the reactant. Thus, it appears that the
iron catalyst catalyzes decarboxylative etherification through the intermediacy of 
π-allyl iron complexes, while allylic alkylation occurs through σ-allyl iron 
complexes.6,9  
2.6 Tandem Aromatic Claisen 
Lastly, we investigated decarboxylative prenylation reactions, since prenyl 
aryl ethers are excellent precursors to biologically active chromans. Interestingly, 
the decarboxylative prenylation reaction provided the 2-prenyl phenol in 
moderate yield.  This product may have arisen from either direct C-allylation of 
the phenolate or via a tandem O-allylation/Claisen rearrangement reaction. The 
mechanism of the transformation appears to be the latter, since direct observation 
of the reaction mixture reveals that the O-allylated product forms at intermediate 
reaction times and is slowly converted to the C-allylated product.  While the yield 
is only moderate, our decarboxylative allylation is more straightforward than 
some related C-prenylations.  For instance, Nicolaou has utilized propargylation 
followed by Lindlar reduction and Claisen rearrangement to control the 
regiochemistry of formal C-allylation of phenols.44-47 Lastly, it is noteworthy that 
attempts to utilize Pd(PPh3)4 to catalyze decarboxylative etherification of 2t led to 
 - 41 -
quantitative elimination, forming 4-methoxyl phenol and isoprene. Thus, the iron 
catalyst exhibits a desirable chemoselectivity favoring substitution over 
elimination. 
Scheme 26: Decarboxylative  prenylation 
 
2.7 Conclusion 
In conclusion, an iron-catalyzed decarboxylative allylation of phenoxides 
was developed.  The yields of the reaction are generally high and the iron catalyst 
often provides chemo- and regioselectivities that complement those of more 
standard palladium catalysts without any β-hydride elimination.  Ultimately, the 
results presented herein show that decarboxylative coupling can be accomplished 
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2.8 Experimental 
Method A: Preparation of unsubstituted allyl carbonates: 
The phenol (620 mg, 5 mmol) and tetra-n-butyl ammonium chloride 
hydrate (9.73mg, 0.035 mmol) were dissolved in dichloromethane (5 mL) and 4M 
sodium hydroxide (2 mL) at 0-5 oC. Allyl chloroformate (681 mg, 5.65 mmol) 
was slowly added and the reaction mixture was stirred for 1 hr. After 1 hr, the two 
layers were separated and the organic layer was washed with 2M sodium 
hydroxide (5 mL) and dried over MgSO4. A yellow oil remained after evaporation 
of the solvent under reduced pressure. This oil was purified by flash column 
chromatography using ethyl acetate and hexanes (1:10) as an eluent, (72% yield). 
 
Method B: Preparation of substituted allyl carbonates: 
A solution of alcohol (e.g. cinnamyl alcohol (642mg, 4.8 mmol)), and 
phenyl chloroformate (500 mg, 3.2 mmol) in dichloromethane (5 mL) was stirred 
for 30 minutes. A catalytic amount of dimethyl amino pyridine (DMAP, 39 mg, 
0.32 mmol) and pyridine (302 mg, 3.83 mmol) were added to the reaction mixture 
and stirred at room temperature for 3–5 hours or until TLC showed complete 
consumption of starting materials. The reaction mixture was washed with 1N HCl 
(3 x 10 ml) and the organic layer was dried over MgSO4. After evaporation of the 
solvent, the remaining yellow oil was purified by flash column chromat gr phy 
with ethyl acetate and hexanes (1:10), (89% yield). 
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General experimental procedure for iron-catalyzed decarboxylative allylic 
etherification: 
A mixture of triphenylphosphine (14.7 mg, 0.05 mmol) and 
Bu4N[Fe(CO)3(NO)] ( 23.2 mg, 0.05 mmol) in methyl-t-butyl ether (MTBE) (2 
mL) was heated at 80 oC for 30 minutes in a pressure vial with a stirring bar. After 
cooling to ambient temperature, the aryl allyl carbonate (0.5 mmol) was added 
and the vial was sealed and heated again at 80 oC until complete conversion 
(monitored by TLC). Purification was performed directly by column 
chromatography using ethyl acetate and hexanes (1:10). The products were 
obtained as colorless oils or white solids. 
 
Decarboxylative allylic etherification and tandem aromatic Claisen: 
Representative procedure for 4-methoxyphenyl 3-methylbut-2-enyl 
carbonate: 
A mixture of triphenylphosphine (11.1 mg, 0.04 mmol) and 
Bu4N[Fe(CO)3(NO)] (17.4 mg, 0.04 mmol) in dry toluene (2 mL) was heated at 
80 oC for 30 minutes in a pressure vial with a stirring bar. After cooling to 
ambient temperature, the for 4-methoxyphenyl 3-methylbut-2-enyl carbonate 
(100mg, 0.423 mmol) was added and the vial was sealed and heated again at 110 
oC until complete conversion was evident (monitored by TLC). The solvent was 
removed under reduced pressure and the crude product was subjected to column 
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chromatography using ethyl acetate and hexanes (1:10). The product was obtained 
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3a: Allyloxybenzene:1 Colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.21 
(m, 3H: ArH overlapping with CHCl3), 7.01 – 6.84 (m, 3H:ArH), 6.12 – 6.01 (m, 
1H:CH=CH2), 5.42 (d, J = 17.3, 1HE:CH=CH2), 5.29 (d, J = 10.7, 1HZ:CH=CH2), 
4.54 (d, J = 5.3, 2H:CH2-CH=).
 13C NMR (126 MHz, CDCl3) δ 158.9 (Quat, ArC-
O-CH2), 134.0 (ArCH), 133.6 (CH=CH2), 129.0 (ArCH), 121.1 (ArCH), 117.9 
(CH=CH2), 115.0 (ArCH), 69.0 (O-CH2-CH=). νmax 2976, 1544, 1219, 1290, 
994, 889 cm-1. 
 
                                                
1 Satoh T., Ikeda M., Miura M., Nomura M., J. Org. Chem., 1997, 62, 4877 – 4879. 
102030405060708090100110120130140150160170180190200
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3b: 1-(allyloxy)-4-methoxybenzene:2 Colorless oil; 1H NMR (500 MHz, CDCl3) 
δ 6.90 – 6.78 (m, 4H:ArH), 6.09-6.01 (m, 1H:CH=CH2), 5.40 (d, J = 17.3, 
1HE:CH=CH2), 5.27 (d, J = 10.5, 1HZ:CH=CH2), 4.49 (d, J = 5.3, 2H:CH2-CH=), 
3.77 (s, 3H:O-CH3). 
13C NMR (126 MHz, CDCl3) δ 154.2 (Quat, ArC-OMe), 
153.0 (Quat, ArC-O-CH2), 133.9 (CH=CH2), 117.8 (CH=CH2), 116.0 & 114.9 
(ArCH), 69.8 (O-CH2-CH=), 56.0 (CH3-OAr). νmax 1508, 1230, 1039, 478, 459, 
447 cm-1. 
 
                                                
2 Jimenez-Gonzalez, L., Alvarez-Corral, M., Munoz-Dorado, M., Rodriguez-Garcia, I., Chem. Comm., 2005, 7, 933 – 
935. 
102030405060708090100110120130140150160170180190200
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3c: 5-(allyloxy)-2-chloro-1, 3-dimethylbenzene: Colorless oil; 1H NMR (500 
MHz, CDCl3) δ 6.65 (s, 2H:ArH), 6.07-5.99 (m, 1H:CH=CH2) , 5.40 (d, J = 
17.26, 1HE:CH=CH2), 5.28 (d, J = 10.51, 1HZ:CH=CH2), 4.49 (d, J = 5.3, 
2H:CH2-CH=), 2.34 (s, 6H:CH3).; 
13C NMR (126 MHz, CDCl3) δ 156.7 (Quat, 
ArC-O) , 137.4 (Quat, ArC-C), 133.5 (CH=CH2), 126.7 (Quat, ArC-Cl), 118.0 
(CH=CH2), 115.0 (ArCH), 69.2 (O-CH2-CH=), 21.3 (C-Ph). νmax 2950, 1589, 
1471, 1170, 1039, 993 cm-1;  HRMS calcd. for C11H13OCl (M
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3d: 2-(allyloxy)-1, 4-dimethylbenzene:3 Colorless oil; 1H NMR (500 MHz, 
CDCl3) δ 7.02 (d, J = 7.4, 1H:2-ArH), 6.68 (d, J = 7.5, 1H:5-ArH), 6.64 (s, 1H:3-
ArH), 6.16 – 6.01 (m, 1H:CH=CH2), 5.44 (d, J = 17.3, 1HE:CH=CH2), 5.27 (d, J 
= 10.6, 1HZ:CH=CH2), 4.53 (d, J = 5.0, 2H:CH2-CH=), 2.32 (s, 3H:4-CH3-Ar), 
2.21 (s, 3H: 3H:2-CH3-Ar).
 13C NMR (126 MHz, CDCl3) δ 156.5 (Quat., ArC-O), 
136.4 (Quat, Ar 4-C-CH3), 133.7 (CH=CH2), 130.4 (ArCH), 123.7 (Quat, Ar 1-C-
CH3), 120.9 (ArCH), 116.7 (CH=CH2), 112.3 (ArCH), 68.6 (O-CH2-CH=), 21.4 





                                                
3 Petit, P., Bourgeois, P., J.Chem. Res., 2004, 3, 194 – 195. 
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3e: 1-(allyloxy)-3, 5-dimethoxybenzene: Colorless oil; 1H NMR (500 MHz, 
CDCl3) δ 6.20 – 5.92 (m, 4H: 3ArH overlapping 1CH=CH2), 5.41 (d, J = 17.2, 
1HE:CH=CH2), 5.29 (d, J = 10.5, 1HZ:CH=CH2), 4.49 (d, J = 5.3, 2H:CH2-CH=), 
3.77 (s, 6H:O-CH3).
 13C NMR (126 MHz, CDCl3) δ 161.7 (Quat, ArC-OMe), 
160.7 (Quat, ArC-O-CH2), 133.4 (CH=CH2), 118.2 (CH=CH2), 93.8 & 93.3 
(ArCH), 101.2 (ArCH), 69.9 (O-CH2-CH=), 55.6 (CH3-OAr). νmax 1598, 1205, 
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3f: 2-(allyloxy)-1, 3, 5-trimethylbenzene:4 Colorless oil; 1H NMR (500 MHz, 
CDCl3) δ 6.83 (s, 2H: ArH), 6.20 – 6.04 (m, 1H:CH=CH2), 5.43 (d, J = 17.2, 
1HE:CH=CH2), 5.26 (d, J = 10.4, 1HZ:CH=CH2), 4.28 (d, J = 5.6, 2H:CH2-CH=), 
2.25 (s, 9H: 2, 4 & 6-CH3-Ar).
 13C NMR (126 MHz, CDCl3) δ 154.0 (Quat., ArC-
O), 134.6 (Ar-CH), 133.4 (CH=CH2), 130.9 (Quat, 4-ArC-Me), 129.6 (2,6-ArC-
Me), 117.4 (CH=CH2), 73.5 (O-CH2-CH=), 21.0 (4-CH3-Ar) 16.6 (2 & 6-CH3-
Ar). δ 154.01, 134.59, 133.44, 130.96, 129.67, 117.41, 73.51, 21.01, 16.62. νmax 
1934, 1483, 1458, 1307, 1261, 1213, 1147, 1035, 696 cm-1. 
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3g: 1-(allyloxy)-3-methoxybenzene:5 Colorless oil; 1H NMR (500 MHz, CDCl3) 
δ 7.18 (t, J = 8.2, 1H: ArH), 6.58 – 6.45 (m, 3H:ArH), 6.13 – 5.99 (m, 
1H:CH=CH2), 5.42 (d, J = 17.3, 1HE:CH=CH2), 5.29 (d, J = 10.5, 1HZ:CH=CH2), 
4.52 (d, J = 5.3, 2H:CH2-CH=), 3.79 (s, 3H:O-CH3).
 13C NMR (126 MHz, CDCl3) 
δ 160.8 (Quat, ArC-OMe), 159.8 (Quat, ArC-O-CH2), 133.2 (CH=CH2), 129.8 
(ArCH) 117.7 (CH=CH2), 106.8 & 106.4 (ArCH), 101.2 (ArCH), 68.82 (O-CH2-
CH=), 55.26 (CH3-OAr). νmax 2840, 1593, 1454, 1434, 1288, 1259, 1118, 1093, 
1043, 748, 696, 541, 503 cm-1. 
                                                
5 Gozzo, F. C., Fernandes, S. A., Rodrigues, D., Eberlin, M., Marsaioli, A. J., J. Org. Chem., 
2003, 68, 5493 – 5499. 
 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
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3h: 1-(allyloxy)-3, 5-dimethylbenzene:6 Colorless oil; 1H NMR (500 MHz, 
CDCl3) δ 6.60 (s, 1H:ArH), 6.55 (s, 2H:ArH), 6.15 – 5.91 (m, 1H:CH=CH2), 5.40 
(d, J = 17.3, 1HE:CH=CH2), 5.27 (d, J = 10.5, 1HZ:CH=CH2), 4.50 (d, J = 5.3, 
2H:CH2-CH=), 2.28 (s, 6H: 2& 4-CH3-Ar).
 13C NMR (126 MHz, CDCl3) δ 158.9 
(Quat., ArC-O), 139.5 (Quat, Ar 3 C-CH3), 133.8 (CH=CH2), 132.4 (ArCH), 
122.9 (ArCH) 117.8 (CH=CH2), 112.7 (ArCH), 68.9 (O-CH2-CH=), 21.4 (CH3-
Ar). νmax 2918, 1595, 1170, 1155, 991, 925 cm-1. 
                                                
6 Won Y., Im E., Org. Lett, 2005, 7, 3355–3358. 
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
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3i: 2-(allyloxy)-4-isopropyl-1-methylbenzene:7 Colorless oil; 1H NMR (500 
MHz, CDCl3) δ 7.07 (d, J = 7.6, 1H: ArH), 6.75 (d, J = 7.6, 1H: ArH), 6.70 (s, 
1H: ArH), 6.16 – 5.99 (m, 1H:CH=CH2), 5.45 (d, J = 17.3, 1HE:CH=CH2), 5.28 
(d, J = 10.6, 1HZ:CH=CH2), 4.56 (d, J = 5.0, 2H:CH2-CH=), 2.86 (dt, J = 6.9, 
13.8, 1H: HC(CH3)2), 2.22 (s, 3H:1-CH3-Ar), 1.24 (s, 6H:4-HC(CH3)2).
 13C NMR 
(126 MHz, CDCl3) δ 156.9 (Quat., ArC-O), 148.1 (ArC-C(CH3)2), 134.1 
(CH=CH2), 130.7 (Ar 6-CH), 124.5 (Quat, Ar 1-C-CH3), 118.5 (Ar 5-CH), 117.1 
(CH=CH2), 110.1 (Ar 3-CH), 69.0 (O-CH2-CH=), 34.3 (Ar-HC(CH3)2), 24.4 
(HC(CH3)2), 16.2 (1-CH3-Ar). νmax 2960, 1415, 1093, 1029, 1925, 808 cm
-1. 
                                                
7 Petit, P., Bourgeois, P., J.Chem. Res., 2004, 3, 194 – 195. 
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3j: 2-(allyloxy)-1-isopropyl-4-methylbenzene: Colorless oil; 1H NMR (500 
MHz, CDCl3) δ 7.11 (d, J = 7.6, 1H: ArH), 6.76 (d, J = 7.7, 1H: ArH), 6.67 (s, 
1H: ArH), 6.16 – 6.01 (m, 1H:CH=CH2), 5.44 (d, J = 17.3, 1HE:CH=CH2), 5.27 
(d, J = 10.6, 1HZ:CH=CH2), 4.54 (d, J = 4.9, 2H:CH2-CH=), 3.33(dt, J = 6.9, 
13.8, 1H: HC(CH3)2), 2.32 (s, 3H:1-CH3-Ar), 1.22 (s, 6H:4-HC(CH3)2). 
13C NMR 
(126 MHz, CDCl3) δ 155.9 (Quat., ArC-O), 136.5 (Quat, Ar 1-C-CH3), 134.6 
(Quat, ArC-C(CH3)2), 134.1 (CH=CH2), 126.2 (ArCH), 121.6 (ArCH), 116.9 
(CH=CH2), 112.9 (ArCH), 69.0 (O-CH2-CH=), 26.9 (Ar-HC(CH3)2), 23.2 
(HC(CH3)2), 21.7 (1-CH3-Ar). νmax 2960, 2923, 1415, 1257, 1093, 1029, 808 
cm-1; HRMS calcd. for C13H18O (M+Na) 213.1255; found 213.1249. 
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3k: 1-(allyloxy)-2-bromobenzene:8 Colorless oil; 1H NMR (500 MHz, CDCl3) δ 
7.54 (d, J = 7.9, 1H: ArH), 7.24 (m, 1H:ArH overlapping CHCl3), 6.90-6.82 (m, 
2H: ArH) 6.11 – 6.03 (m, 1H:CH=CH2), 5.49 (d, J = 17.3, 1HE:CH=CH2), 5.31 
(d, J = 10.6, 1HZ:CH=CH2), 4.52 (d, J = 5.0, 2H:CH2-CH=).
 13C NMR (126 MHz, 
CDCl3) δ 155.2 (Quat, ArC-O-CH2), 133.7 (CH=CH2), 132.7 (ArCH), 128.7 
(ArCH), 122.3 (ArCH), 118.1 (CH=CH2), 113.8 (ArCH), 112.5 (Quat, ArC-Br), 
69.9 (O-CH2-CH=). νmax 1479, 1292, 1276, 1247, 1051, 997, 929 cm
-1.  
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3l: 1-(allyloxy)-4-methoxybenzene:9 Colorless oil; 1H NMR (500 MHz, CDCl3) 
δ 6.84 (q, J = 9.3, 4H:ArH), 5.08 (d, J = 0.7, 1H: -C(CH3)=CH2), 4.97 (s, 1H: -
C(CH3)=CH2), 4.38 (s, 2H: CH2-C(CH3)), 3.77 (s, 3H:O-CH3), 1.87 (s, 3H: -
C(CH3)=CH2). 
13C NMR (126 MHz, CDCl3) δ 154.1 (Quat, ArC-OMe), 153.2 
(Quat, ArC-O-CH2), 141.5 (Quat, -C(CH3)=CH2), 116.0 & 114.8 (ArCH), 112.9 
(-C(CH3)=CH2), 72.7 (O-CH2-C=), 56.0 (CH3-OAr), 19.8 (-C(CH3)=CH2) νmax 
2929, 1508, 1228, 1039, 823 cm-1. 
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3m: 1-(cinnamyloxy)-4-methoxybenzene: White solid; 1H NMR (500 MHz, 
CDCl3) δ 7.47 – 7.18 (m, 8H: ArH overlapping CHCl3), 6.87(dd, J = 9.2, 31.9, 
4H:ArH), 6.72 (d, J = 16.0, 1H: CH=CH-CH2), 6.43-6.38 (m, 1H:CH=CH-CH2), 
4.65 (d, J = 5.8, 2H: CH=CH-CH2), 3.77 (s, 3H: OCH3). 
13C NMR (126 MHz, 
CDCl3) δ 154.3, (Quat, ArC-OMe), 153.1 (Quat, ArC-O), 136.8 (Quat, ArC-
CH=CH), 133.2 (ArCH), 128.9 (ArCH), 128.2 (ArCH), 126.9 (CH=CH-CH2), 
125.1 (CH=CH-CH2), 116.1 (ArCH), 114.9 (ArCH), 69.7 (O-CH2-CH=), 56.1 
(CH3O-Ar). νmax 2852, 1501, 1401, 1218, 1132, 880 cm
-1.  HRMS calcd. for 
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1-bromo-4-(cinnamyloxy)benzene: White solid; 1H NMR (500 MHz, CDCl3) δ 
7.45 – 7.24 (m, 7H: ArH overlapping CHCl3), 6.85(d, J = 9.1, 2H: ArH), 6.73 (d, 
J = 16.0, 1H: CH=CH-CH2), 6.43-6.37 (m, 1H:CH=CH-CH2), 4.68 (d, J = 5.8, 
2H: CH=CH-CH2). 
13C NMR (126 MHz, CDCl3) δ 158.0 (Quat, ArC-O), 136.5 
(Quat, ArC-CH=CH), 133.5 (Ar 2,6-CH), 128.9 (ArCH), 128.3 (ArCH), 126.9 
(CH=CH-CH2), 124.2 (CH=CH-CH2), 116.9 (Ar 3,5-CH),  113.1 (Quat, ArC-Br), 
69.7 (O-CH2-CH=). νmax 2148, 1949, 1487, 1240, 692 cm
-1. HRMS calcd. for 
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3o: 1-(cinnamyloxy)-3-(trifluoromethyl) benzene: White solid; 1H NMR (500 
MHz, CDCl3) δ 7.39 – 7.05 (m, 12H: ArH overlapping CHCl3), 6.69(d, J = 16.0, 
1H: CH=CH-CH2), 6.37-6.31 (m, 1H:CH=CH-CH2), 4.67 (d, J = 5.8, 2H: 
CH=CH-CH2). 
13C NMR (126 MHz, CDCl3) δ 159.0 (Quat, ArC-O), 136.5 (Quat, 
ArC-CH=CH), 133.9 (ArC), 130.3 (ArC), 128.9 (ArC), 126.4 (CH=CH-CH2), 
126.9 (CH=CH-CH2), 123.9 (ArC), 118.5 (ArC), 117.9(ArC), 69.1 (O-CH2-CH=). 
Can’t detect CF3 and CF3-CAr quaternary carbons. νmax 2923, 1591, 1326, 1126, 
1020, 792 cm-1;  HRMS calcd. for C16H13F3O (M+Na) 301.0816; found 301.0818. 
OF3C
3o
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3p: Methyl 4-(cinnamyloxy)benzoate: White solid; 1H NMR (500 MHz, CDCl3) 
δ 8.00 (d, J = 9.0, 2H: ArH), 7.47 – 7.21 (m, 9H: ArH overlapping CHCl3), 
6.98(d, J = 9.0, 2H: 2,6-ArH), 6.75 (d, J = 16.0, 1H: CH=CH-CH2), 6.44-6.38 (m, 
1H:CH=CH-CH2), 4.76 (d, J = 5.8, 2H: CH=CH-CH2), 3.89 (s, 3H: CH3OCO), 
13C NMR (126 MHz, CDCl3) δ 167.2 (Quat, CH3OCO), 162.6 (Quat, ArC-O), 
136.5 (Quat, ArC-CH=CH), 133.9 (ArCH), 131.9 (ArCH), 128.9 (ArCH), 128.4 
(CH=CH-CH2), 126.9 (CH=CH-CH2), 123.8 (ArCH), 123.0 (Quat, ArC-
COOCH3), 114.6 (ArCH),  113.1 (Quat, ArC-Br), 69.0 (O-CH2-CH=), 52.26 (CH-
3OCO). νmax 2862, 1456, 1172, 1110, 499 cm
-1
;  HRMS calcd. for C17H16O3 
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3q: 1-(cinnamyloxy)-2-methoxybenzene: White solid; 1H NMR (500 MHz, 
CDCl3) δ 7.50 – 7.12 (m, 6H: ArH overlapping CHCl3), 6.98 – 6.78(m, 4H: ArH), 
6.66 (d, J = 16.0, 1H: CH=CH-CH2), 6.44-6.39 (m, 1H:CH=CH-CH2), 4.72 (d, J 
= 5.9, 2H: CH=CH-CH2), 3.83 (s, 3H: OCH3). 
13C NMR (126 MHz, CDCl3) δ 
149.6, (Quat, ArC-OMe), 148.2 (Quat, ArC-O), 136.7 (Quat, ArC-CH=CH), 
133.5 (ArCH), 128.8 (ArCH), 128.1 (ArCH), 126.8 (CH=CH-CH2), 124.8 
(CH=CH-CH2), 121.5 (ArCH), 121.0 (ArCH)  113.7 (ArCH), 111.82 (ArCH), 
69.8 (O-CH2-CH=), 56.1 (CH3O-Ar). νmax 1479, 1332,1284, 1180, 696 cm
-1
;  




 - 62 -
3r: (3-Phenylprop-2-enyl)oxy-benzene:10 White solid; 1H NMR (500 MHz, 
CDCl3) δ 7.42 (d, J = 7.3, 2H:ArH), 7.36 – 7.23 (m, 5H:ArH), 7.00 – 6.92 (m, 
3H:ArH), 6.74 (d, J = 16.0, 1H: CH=CH-CH2), 6.46-6.40 (m, 1H:CH=CH-CH2), 
4.71 (d, J = 5.8, 2H: CH=CH-CH2). 
13C NMR (126 MHz, CDCl3) δ 158.9 (Quat, 
ArC-O), 136.7 (Quat, ArC-CH=CH), 133.3 (Ar 3,5-C), 129.8 (Ar4-C), 128.9 (Ar 
2-C), 128.2 (Ar 6-C), 126.9 (CH=CH-CH2), 124.8 (CH=CH-CH2), 121.2 (Ar 4-C), 
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3s: (but-3-en-2-yloxy) benzene:11 Colorless oil; 25% linear product was 
obtained. 1H NMR (500 MHz, CDCl3) δ 7.51 – 6.8 (m, 11H: ArH of both 
regioisomers, overlapping with CHCl3), 6.04 – 5.83 (m, 1H:CH=CH2:branched 
overlapping with -CH=CH-CH3 of minor linear isomer), 5.78 – 5.69 (m, 
CH=CH2:linear), 5.28 (d, J = 17.3, 1HE:CH=CH2), 5.17 (d, J = 10.6, 
1HZ:CH=CH2), 4.91 – 4.73 (m, 1H:ArO-CH(CH3)CH=), 4.63 – 4.40 (d, ArO-
CH2:linear), 1.77 (d, J = 6.4, -CH=CH-CH3:linear), 1.44 (d, J = 6.4, 3H: ArO-
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CH(CH3)-CH=CH2). 
13C NMR (126 MHz, CDCl3) δ 158.9 (Quat, ArC-O-CH2
 
(linear)), 158.2 (Quat, ArC-O-CH(CH3)
 (branched)), 139.5 (CH=CH2), 134.1 
((ArCH), 134.0 (ArCH), 133.9 (ArCH), 133.0 (ArCH), 131.0 (ArCH), 129.9 
(ArCH), 128.8 (CH2CH=CH-CH3:linear) , 126.3 (CH2CH=CH-CH3:linear), 121.4 
(ArCH), 116.2 (ArCH), 115.9 (CH=CH2), 114.9 (ArCH), 74.8 (ArO-(CH3)CH-
CH=CH2), 68.9 (ArO-CH2-CH=CH-:linear), 21.6 (ArO-(CH3)CH-CH=CH2) , 
18.2 (-CH2CH=CH-CH3:linear).
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3t: 4-methoxy-2-(3-methylbut-2-enyl): Colorless oil; 1H NMR (500 MHz, 
CDCl3) δ 6.84 – 6.58 (m, 3H: ArH), 5.34 – 5.27 (m, 1H:CH=CH2), 4.78 (s, 
1H:Ar-OH), 3.75 (s, 3H:Ar-OCH3), 3.32 (d, J = 7.2, 2H:Ar-CH2-CH=C(CH3)2), 
1.83 – 1.70 (m, 6H: Ar-CH2-CH=C(CH3)2).
 13C NMR (126 MHz, CDCl3) δ 153.9 
(Quat., ArC-OMe), 148.5 (Quat, ArC-OH), 135.2 (Quat, Ar-CH2-CH=C(CH3)2), 
128.3 (Quat, ArC-CH2-CH=), 121.8 (Ar-CH2-CH=C(CH3)2), 116.5 (Ar-CH), 
116.0 (Ar-CH), 112.3 (Ar-CH), 56.0 (ArC-OCH3), 30.3 (Ar-CH2-CH=C(CH3)2), 
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2923, 2854, 2835, 1504, 1433, 1276, 1201, 1110, 1041, 923, 802, 786 cm-1;  
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3.1 Approach 
After a thorough search in literature, we discovered, that decarboxylative 
sp2-sp3 couplings were relatively rare, and required typically harsh temperature 
conditions and heavy catalyst and co-catalyst loadings.1-5 In order to circumvent 
these issues, we embarked upon the discovery of a mild and efficient way to 
achieve a decarboxylative sp2-sp3 coupling. 
We started out with a strategy where we employed an electron 
withdrawing group (EWG) on a vinyl allyl ester (Scheme 27). We reasoned that 
the EWG on the vinyl carbon should help stabilize the incipient negative charge at 
the vinyl carbon as decarboxylation occurs. Thus we began working on esters of 
cyano acrylates (27a) as a starting point. Our rationale was that after the 
formation of the π-allylpalladium species, the resulting cyanoacrylate acetate 
(27c) would decarboxylate to generate a cyano-stabilized vinyl anion (27d). 
Subsequent coupling of the anion (27d) with π-allyl palladium species would lead 
to the formation of the coupling product (27e) and return the Pd(0) catalyst. The 
crux of the whole strategy was embedded in the fact that the generatio  of a vinyl 
anion (27d) would be an unfavorable process and require stabilization from an 
electron withdrawing group like nitrile. 
Although this scheme seems feasible on paper, when put in practice, only 
about 2-3% of the coupling product 27e was isolated. Most of the starting material 
decarboxylated to give the cyanoacrylate and some polymerized products. Similar 
results were obtained with other electron withdrawing groups too. However, it is 
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important to mention here, that Saegusa6 h s shown the decarboxylation of allyl 
2-cyano-2-cyclohexylideneacetate in the presence of Pd(PPh3)4. 
Scheme 27: Strategy for sp2-sp3 coupling 
 
Interestingly, when an ester is employed as an EWG (28c), quantitative π-
allylpalladium formation (28d) was observed by 1H NMR spectroscopy. Digging 
deeper into literature, we found that Corey7.8 has shown in the early 50’s, that 2-
cyanoacrylic acids (28a) readily decarboxylate in presence of nucleophiles like 
DMAP and pyridine. We were able to replicate the same decarboxylation with 
triphenylphosphine as nucleophile and nitrile or esters as the EWG. 
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Scheme 28: Decarboxylation of aryl acrylates 
 
3.2 Proof of concept  
Corey has investigated the mechanism7,8 for this decarboxylation very 
extensively and more recently, Bernhardt Breit9,10 has also used this 
decarboxylation trick in a decarboxylative hydroformylation. They propose the 
attack of a nucleophile on the double bond in order to generate a sp3 anion 29b. 
This resonance stabilized sp3 anion can undergo a proton transfer and pick up a 
proton from the acid to generate the carboxylate 29c. Subsequently 
decarboxylation can occur to regenerate the double bond and quench the charge 
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Scheme 29: Mechanism 
 
Looking at the above data, we decided to employ this strategy for our 
coupling process. We synthesized allyl esters of methylidene malonates (29e) 
replacing the carboxylic acid proton with an allyl group. Much to our 
disappointment, we did not achieve any C–C bond formation (29h) in presence of 
Pd(PPh3)4. We assumed that the phenyl group of 28c was making the benzylic 
position stable and not as electrophilic as we would like it to be. Thus we 
removed the aromatic ring and replaced it with an alkyl chain. Treatment of 
substrate 30a with Pd(PPh3)4 gave us an unexpected result, providing diallylated 
product 30f as the major product in 43% yield. ~5% monoallylated sp2-sp3 
coupled product 30g was also observed. We can explain the formation of 
diallylated product as explained in scheme 30. In presence of Pd(PPh3)4, 30a can 
form the π-allylpalladium and the carboxylate anion 30b. At this point of time, a 
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simple proton transfer to the carboxylate from the acidic γ-protons of the 
methylidene malonate leads to the enolate 30c. This enolate can attack the 
electrophilic π-allylpalladium to give 30d. Decarboxylation of 30d will again give 
us an enolate 30e, which can react with another π-allylpalladium to give the major 
diallylated product 30f. However, if 30b decarboxylates to form a vinyl anion 30h 
and subsequently attacks a π-allylpalladium, we get the minor product 30g. 
 
Scheme 30: Diallylation 
 
 
After the above observation, we realized that presence of acidic protons 
alpha to the double bond, is facilitating this diallylation process. Thus we chose to 
investigate related carboxycoumarin substrates which are analogs of alkylidene 
malonates that lack acidic γ-protons. Herein, we discuss the results. 
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3.3 Initial Experiments 
To begin, Dr. Ranjan Jana and I synthesized allyl 4-nitro-2-oxo-2H-
chromene-3-carboxylate and treated it with Pd(PPh3)4 in CH2Cl2 (Scheme 31).  It 
was gratifying to find the reaction went to 100% conversion, allowing 6- itro 3-
allylcoumarin to be isolated in 73% yield. In addition to the product, 
approximately 10% yield of 6-nitrocoumarin is also formed, which results from 
protonation of a putative coumarin anion equivalent.11 We were aware of the fact 
that decarboxylation of 3-carboxycoumarins can be effected by heating with 
strong acid or base, decarboxylative metalation under neutral conditions is 
difficult. For example, copper-catalyzed decarboxylation of a related 2-
carboxycoumarin takes place at 248 °C in refluxing quinoline.11-13 With that in 
mind, it is particularly noteworthy that the decarboxylative coupling took place at 
just 50 oC. Moreover, the allylation took place without the need for preformed 
organometallics that are typically required for the allylation of sp2 carbons14-19 
and it is more efficient than typical syntheses of 3-allylcoumarins.20,21 
 Scheme 31: Nitro Coumarin pilot 
3.4 Scope 
Next, a range of coumarins were subjected to our standard conditions for 
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good. The reaction is compatible with electron-donating and electron-
withdrawing functional groups. This fact argues against simple electrophilic 
allylation of the coumarin.22, 23 While coumarins with oxygen donors are excellent 
substrates, an amine-containing substrate (Table 4, entry 9) provides a relatively 
low yield of product. Importantly, aryl bromides are tolerated, allowing tandem 
reactions involving decarboxylative coupling and standard cross-coupling 
chemistry. 
Table 4: Decarboxylative coupling of Coumarins 






























































a Isolated yield using 10 mol% Pd(PPh3)4, 50
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Next we turned our attention to the investigation of the coupling of 
substituted allyl electrohphiles with coumarins (Table 5). The coupling of 2-
methallyl alcohol derivatives proceeds smoothly and provides products in 
somewhat higher yields than those without methallyl substituents (Table 5, entries 
1-3). Importantly, the chemistry is also compatible with 3-alkyl-substituted allyl 
groups (Table 5, entries 4-6). This is particularly noteworthy because the coupling 
is the formal allylation of a very basic vinyl anion. Typically, such strong bases 
simply induce elimination of the π-allyl palladium intermediates.24. 25 




















































a Isolated as a 94:6 mixture of linear:branched regioisomers.  
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3.5 Mechanistic investigations and Extensions 
In the interest of exploring the features of the coumarin thatallow 
decarboxylative coupling under such mild conditions, several experiments wre 
performed. First, an acyclic analogue of the coumarin (32a) was subjected to the 
standard reaction conditions for decarboxylative allylation of coumarins, a d it 
did not produce any product. While the reaction with the acyclic derivative failed, 
pyrone (32b) reacts to form the product of decarboxylative coupling (32e) under 
identical conditions to those used in the coumarin coupling.26 Thus, the benzenoid 
ring of the coumarin is not required for reactivity. Lastly, the analogous 
thiocoumarin derivative provided coupling product (32f) in good yield, showing 
that the concept of decarboxylative allylation extends to heteroaromatics other 
than coumarins.  
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Encouraged by the above results, we tried the isomeric chromone and 
isochromone. 
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We observe that while the simple allylesters of chromones (33a-33d) 
decarboxylate to give products in poor to moderate yields, presence of any β-
hydrogens on the allyl fragments (33g-33i) leads to quantitative formation of the 
protonated product and the corresponding diene. It is also noteworthy, that the 
isochromone analog (33f) undergoes no decarboxylation at all, indicating the 
necessity of an electronwithdrawing group on the vinyl carbon to achieve the 
desired decarboxylative coupling. 
While decarboxylative couplings are often used in lieu of standard cross-
coupling reactions that are more costly or wasteful, decarboxylative couplings are 
oftentimes complementary to standard palladium-catalyzed coupling reactions. 
For instance, the decarboxylative sp2-sp3 coupling reported herein can be readily 
utilized in a tandem decarboxylative allylation/Heck olefination sequence to 
provide coumarin 34 (Scheme 34).  






3.6 Controls  
In order to further probe the mechanism of the reaction, we performed the 
following experiments to afford a coupling. 
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Scheme 35: Controls 
 
The above experiments rule out any nucleophile assisted decarboxylation 
suggested by Corey7,8 as discussed earlier. 
3.7 Conclusion 
In conclusion, we have developed an exceptionally mild decarboxylative 
sp2-sp3 coupling that results in the allylation of pharmacologically relevant 
oxygenated heteroaromatics. Continuing studies are aimed at elucidating the 
mechanism of this transformation in hopes of defining the reasons that 
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3.8 Experimental 
Materials. Methylene chloride was dried over activated alumina.12 All reagents 
were used as received unless otherwise stated.  Triethylamine nd methyl acrylate 
were freshly distilled before use. The coumarin 3-allyl ester a ting materials 
were purified by column chromatography and void of any contamination wth 
protic solvents e. g. water or alcohols; the yields of the decarboxylative coupling 
are highly dependent on the purity of the starting material. 1H NMR spectra were 
referenced to residual protio solvent signals. Structural assignments are based on 
1H, 13C, DEPT-135, NOESY, and IR spectroscopies.  
 
Preparation of the staring materials: The starting materials were prepared in 
two steps. In step 1 diallyl malonates were prepared either by acid c talyzed 
condition (Method A) or by Steglich’s conditions (Method B). In step II the 
diallyl malonates were condensed with the substituted salicylaldehydes to obtain 
3-allylcarboxylate-2-chromenones.  
 
Step I, Method A: Preparation of diallyl malonates by acid catalysis:13 
Malonic acid (1.04 g, 10 mmol), allyl alcohol (3 ml, 44 mmol) and p-
toluenesulfonic acid monohydrate (0.113 g, 0.6 mmol) were dissolved in benzene 
(50 mL), and water was removed azeotropically using a Dean-Stark apparatus. 
After 6 hours the reaction was complete as shown by TLC as well as the 
calculated amount of water accumulation in the Dean-Stark apparatus. The 
apparatus was cooled to ambient temperature. The benzene solution was diluted 
with diethyl ether (50 ml) and washed with saturated aqueous NaHCO3 (2x15 
                                                
12 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  
Organomettalics, 1996, 1518-1520.  
 
13 Imao, D.; Itoi, A.; Yamazaki, A.; Shirakura, M.; Ohtoshi, R.; Ogata, K.; Ohmori, Y.; 
Ohta, T.; Ito, Y. J. Org. Chem. 2007, 1652-1658. 
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mL) brine (15 mL) and dried over anhydrous Na2SO4. A yellow liquid remained 
after evaporation of the solvent under reduced pressure. This residue was purified 
by flash column chromatography with ethyl acetate/hexane (1:10), to obtain the 
pure product as yellow oil (1.74 g, 95% yield). 
Step 1, Method B: Preparation of diallyl malonates using Steglich’s 
Conditions:14 
Malonic acid (2.2 mmol, 1.1 equiv), DMAP ( 0.1 equiv) and DCC (2.2 mmol, 1.1 
equiv), were successively added to a solution of respective allyl alcohols (2.0 
mmol, 1.0 equiv) in dry dichloromethane (10 mL) and the resulting mixture was 
stirred at room temperature until TLC showed complete consumption of the 
starting materials. Subsequently, the mixture was filtered and concentrated. 
Purification of the residue by flash chromatography (ethyl acetate, hexane, 20:80) 
afforded the pure product of malonate ester.  
 
Step 2: Preparation of 3-allyl carboxylate chromene- 2-one:15  
In a round bottomed flask equipped with a reflux condenser were placed 
salicylaldehyde (122 mg, 1.0 mmol), diallyl malonate (220 mg, 1.2 mmol) and 
absolute ethanol (5 mL). To this reaction mixture were added piperidine (100 µL) 
and glacial acetic acid (5 µL). The reaction mixture was refluxed for 3 hours. 
After the completion of the reaction was indicated by TLC, the solution was 
cooled to ambient temperature and the ethanol was evaporated under reduced 
pressure, diluted with ethyl acetate (10 ml) and washed subsequently with 
saturated NaHCO3 (2x5 mL), 1 (N) HCl (5 mL), water (5 mL), brine (5 mL) and 
dried over anhydrous Na2SO4.  Evaporation of the solvent under reduced pressure 
left the crude product which was purified by flash column chromatogrphy (ethyl 
acetate, hexane, 30:70) to obtain 210 mg pure 3-allyl carboxylate chromene- 2-
one (94% yield).  
                                                
14 Neises, B.; Steglich, W.; Organic Syntheses, 1985, 63, 183-187.  
15 Organic Syntheses, Coll. Vol. 3, p.165 (1955). 
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3-Allyl carboxylate thiochromene- 2-one was prepared by the modified l terature 
procedure.5 
 
General experimental procedure for the decarboxylative sp2-sp3 coupling of 
coumarin 3-allyl esters: 
 
Representative experimental procedure for 3-allyl-6-nitro-2H-chromen-2-one 
(entry 3, Table 4) A mixture of allyl 6-nitro-2-oxo-2H-chromene-3-carboxylate 
(4a, 110 mg, 0.4 mmol, entry 3, Table 1) and Pd(PPh3)4 (46 mg, 10 mol%) was 
added to a thick-walled reaction tube under argon atmosphere in an inert 
atmosphere glove box.  This mixture was dissolved in dry dichloromethane (6 
mL) and heated at 50 oC for 14 h in the sealed tube. After the completion of the 
reaction was indicated by TLC, the reaction mixture was concentrat d under 
reduced pressure and the residue was purification by flash column 
chromatography using ethyl acetate, hexane (20:80) to provide 66 mg pure 3-
allyl-6-nitro-2H-chromen-2-one (73% yield) as yellowish solid. 
 
The same procedure was followed for all the simple allyl coumarins 
(Table 1), substituted allyl coumarins (Table 2).  The same procedure was 
followed to produce pyranone, but due to high volatility of the product, 
dichloromethane was used as an eluent for column chromatography and the 
solvent was evaporated under a stream of nitrogen in lieu of using reduced 
pressure.  The reaction to produce chromenone was performed at room 
temperature. For the 3-allyl carboxylate thiochromene- 2-one the reaction was 
performed at 30 oC. 
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Tandem Heck and sp2-sp3 coupling of allyl-6-bromo-2-oxo-2H-chromene-3-
carboxylate (Compound 34):16 
A mixture of allyl 6-bromo-2-oxo-2H-chromene-3-carboxylate (62 mg, 0.20 
mmol), freshly distilled methyl acrylate (0.22 mL, 0.40 mmol), triethylamine 
(0.35 mL, 0.40 mmol), and Pd(PPh3)4 (23 mg, 0.02 mmol) was placed in a 
reaction tube under argon in an inert atmosphere glove box and was diluted with 
toluene (5 mL). The sealed reaction tube was heated at 100 oC for 4 h. After the 
consumption of the starting materials was indicated by TLC, the reaction mixture 
was diluted with ethyl acetate (10 mL) and washed with 1(N) HCl (2 mL), water 
(2 mL), brine (5 mL) and dried over anhydrous Na2SO4.  Evaporation of the 
solvent under reduced pressure left the crude product which was purified by flash 
column chromatography on silica gel using ethyl acetate/hexane (30:70) eluent.  
















                                                
5Patel, B. A.; Ziegler, C. B.; Cortese, N. A.; Plevyak, J. E.; Zebovitz, M. T.; Heck, R. F. 
J. Org. Chem. 1977, 3903-3907. 




























3-Allyl-6-nitro-2H-chromen-2-one (31): Pale yellow solid, m. p. 124 oC; 1H 
NMR (500 MHz, CDCl3) δ ppm 8.39 (d, J = 2.65 Hz, Ar CH), 8.34 (dd, J1 = 6.40 
Hz, J2 = 2.65 Hz, Ar CH), 7.58 (s, C4-H), 7.44 (d, J = 8.95 Hz, Ar CH), 5.92-5.97 
(m, CH=CH2), 5.24-5.29 (m, CH=CH2 ), 3.36 (dq, J1 = 6.75 Hz, J2 = 1.25 Hz, 
CH2-CH=); 
13C NMR (126 MHz, CDCl3) δ ppm 159.96 (C=O, quat.), 156.56 (Ar 
C, quat.), 144.03 (Ar C, quat.), 137.46 (C4-H), 133.25 (CH=CH2), 130.75 (C3, 
quat.), 125.58 (Ar CH) , 123.16, 119.50 (Ar C, quat.), 119.26 (Ar CH), 117.61 
(CH=CH2), 34.57 (CH2-CH=); IR (CH2Cl2): ν 2962, 1714 (C=O), 1587 (C=C), 
1159, 1056, 923 cm-1; Calcd. HRMS for C12H9NO4 (M


































3-Allyl-2H-chromen-2-one (Table 4, entry 1):17 Colourless solid, m. p. 44 oC; 
1H NMR (500 MHz, CDCl3) δ ppm 7.44 (s, C4-H), 7.36-7.42 (m, 2Ar CH), 7.25 
(dd, J1 = 8.35 Hz, J2 = 0.5 Hz, Ar CH), 7.17-7.20 (m, Ar CH), 5.87-5.95 (m, 
CH=CH2), 5.14-5.18 (m, CH=CH2), 3.26 (dq, J1 = 6.75 Hz, J2 = 1.30 Hz, CH2-
CH=); 13C NMR (126 MHz, CDCl3) δ ppm 161.60 (C=O, quat.), 153.14 (Ar C, 
quat.), 138.92 (C4-H), 133.79 (CH=CH2), 130.75 (Ar CH), 128.05 (Ar CH), 
127.28 (C3, quat.), 124.31(Ar CH), 119.46 (Ar C, quat.), 118.21 (CH=CH2), 
116.47 (Ar CH), 34.54 (CH2-CH=) ; IR (CH2Cl2): ν 2925, 1768 (C=O), 1623 
(C=C), 1595, 1500, 1454, 1421, 1205, 1127, 1099, 698 cm-1; Calcd. HRMS for 
C12H10O2 (M+Na), 209.0578; Found, 209.0573.  
                                                
17 Mali, R. S.; Tilve, S. G.; Yeola, S. N.; Manekar, A. R. Heterocycles, 1987, 121-127.   



























3-Allyl-7-methoxy-2H-chromen-2-one (Table 4, entry 2):18 Colourless solid, m. 
p. 54 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.44 (s, C4-H), 7.33 (d, J= 8.35 Hz, 
Ar CH), 6.84 (d, J = 2.40 Hz, Ar CH), 6.80-6.83 (m, Ar CH), 5.92-6.00 (m, 
CH=CH2), 5.18-5.22 (m, CH=CH2), 3.85 (s, OCH3), 3.29 (dq, J1 = 6.80 Hz, J2 = 
1.25 Hz, CH2-CH=); 
13C NMR (126 MHz, CDCl3) δ ppm 161.97 (C=O, quat.), 
161.94 (C7, quat.), 154.82 (Ar C, quat.), 139.08 (C4-H), 134.17 (CH=CH2) 
128.15 (Ar CH), 124.35 (C3, quat.), 117.85 (CH=CH2), 113.10 (Ar C, quat.), 
112.44 (Ar CH), 100.49 (Ar CH), 55.72 (OCH3), 34.39 (CH2-CH=); IR (CH2Cl2): 
ν 2962, 1714 (C=O), 1587 (C=C), 1159, 1056, 923 cm-1; Calcd. HRMS for 
C13H12O3Na (M+Na), 239.0684; Found, 239.0687. 
                                                
18 Mali, R. S.; Tilve, S. G.; eola, S. N.; Manekar, A. R. Heterocycles, 1987, 121-127. 

























3-Allyl-7-nitro-2H-chromen-2-one (Table 4, entry 3):19 Pale yellow solid, m. p. 
63 oC; 1H NMR (500 MHz, CDCl3) δ ppm 8.16 (d, J = 2.20 Hz, Ar CH), 8.12 (dd, 
J1 = 6.35 Hz, J2 = 2.20 Hz, Ar CH), 7.62 (d, J =  8.50 Hz, Ar CH), 7.57 (s, C4-H), 
5.92-6.00 (m, CH=CH2), 5.24-5.29 (m, CH=CH2), 3.36 (dq, J1 = 6.80 Hz, J2 = 
1.25 Hz, CH2-CH=); 
13C NMR (126 MHz, CDCl3) δ ppm 160.12 (C=O, quat.), 
152.99 (Ar C, quat.), 148.43 (Ar C, quat.), 136.95 (C4-H), 132.64 (Ar CH), 
132.21 (Ar C, quat.), 128.13 (CH=CH2), 124.37 (C3, quat.), 119.37 (Ar CH), 
119.16 (CH=CH2), 112.26 (Ar CH), 34.77 (CH2-CH=); IR (CH2Cl2): ν 2962, 
1712 (C=O), 1565 (C=C), 1161, 1057, 926, 755 cm-1; Calcd. HRMS for 
C12H9NO4 (M
+), 231.0532; Found, 231.0537.   
                                                
19 Black, M.; Cadogan, J. I. G.; McNab, H.; MacPherson, A. D.; Roddam, V. P. Smith, 
C.; Swenson, H. R. J. Chem. Soc. Perkin Trans. 1, 1997, 2483-2493. 
 






























3-Allyl-8- tert-butyl-6-methoxy-2H-chromen-2-one (Table 4, entry 4): Off-
white solid, m. p. 95 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.44 (s, C4-H), 7.06 
(d, J = 3.00 Hz, C5-H),  6.71 (d, J = 3.00 Hz, C7-H), 5.94-6.01 (m, CH2-C=H), 
5.21-5.24 (m, HC=CH2), 3.32 (dd, J1 = 6.80 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C 
NMR (126 MHz, CDCl3) δ ppm 161.47 (C=O), 155.45 (C6, quat.), 146.99 (C8, 
quat), 139.81 (C4), 139.53 (C9, quat.), 134.11 (CH2=CH), 127.55 (C10, quat.), 
120.26 (C3, quat.), 118.28 (CH=CH2), 117.46 (C7), 106.60 (C5), 55.76 (OCH3), 
35.14 (CCH3, quat.), 32.85 (CH-CH2), 28.20 (CCH3); IR (CH2Cl2): ν 2962, 1714 
(C=O), 1587 (C=C), 1461, 1434, 1159, 1056, 1027, 1002, 757 cm-1; Calcd. HRMS 
for C17H20O3Na (M+Na), 295.1316; Found, 295.1297. 

































3-Allyl-6-methyl-2H-chromen-2-one (Table 4, entry 5): Colourless solid, m. p. 
39 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.51 (s, C4-H), 7.32-7.34 (m, 2ArCH), 
7.26-7.29 (m, 2ArCH), 5.99-6.06 (m, CH2-C=H), 5.25-5.30 (m, HC=CH2), 3.37 
(dd, J1 = 6.80 Hz, J2 = 1.25 Hz, CH2-C=H), 2.45 (s, ArCH3); 
13C NMR (126 
MHz, CDCl3) δ ppm 161.88 (C=O), 151.24 (C6, quat.), 138.97 (C4), 133.96 (C9, 
quat.), 133.91 (CH2=CH), 131.75 (C8), 127.82 (C10, quat.), 127.14 (C5), 119.19 
(C3, quat.), 118.18 (CH=CH2), 116.17 (C7), 34.56 (CH-CH2), 20.81 (ArCH3); IR 
(CH2Cl2): ν 2965, 1708 (C=O), 1582 (C=C), 1466, 1432, 1159, 1056, 1027, 957 
cm-1; Calcd. HRMS for C17H20O3Na (M+Na), 223.0735; Found, 223.0728. 
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3-Allyl-6-bromo-2H-chromen-2-one (Table 4, entry 6): Colourless solid, m.p. 
94 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.57 (d, J = 2.20 Hz, C5-H), 7.53-7.56 
(m, C7-H), 7.41 (s, C4-H), 7.20 (d, J = 8.65 Hz, C8-H), 5.90-5.98 (m, CH2-C=H), 
5.20-5.28 (m, HC=CH2), 3.32 (dq, J1 = 6.75 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C 
NMR (126 MHz, CDCl3) δ ppm 160.93 (C=O, quat.), 151.93 (Ar C, quat.), 
137.54 (Ar CH), 133.68, (Ar CH), 133.30 (CH2=CH), 129.88 (Ar CH), 129.41 
(Ar C, quat.), 120.98 (Ar C, quat.),  118.71 (Ar CH),  118.21(CH=CH2), 116.87 
(Ar C, quat.), 34.55 (CH-CH2); IR (CH2Cl2): ν 2969, 1712 (C=O), 1587 (C=C), 
1476, 1147, 1136, 1046, 951 cm-1; Calcd. HRMS for C12H9BrO2Na (M+Na), 
286.9684; Found, 286.9641. 
 






























3-Allyl-6,8-dibromo-5,7-dimethoxy-2H-chromen-2-one (Table 4, entry 7): 
Pale yellow solid, m. p. 92 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.66 (t, J = 
1.25 Hz, C4-H), 5.92-6.00 (m, CH2-C=H), 5.21-5.25 (m, HC=CH2), 3.95 (s, 
OCH3), 3.93 (s, OCH3) 3.35 (dq, J1 = 6.65 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C 
NMR (126 MHz, CDCl3) δ ppm 160.12  (C=O), 156.86 (Ar C, quat.), 153.61 (Ar 
C, quat.), 150.50 (Ar C, quat.), 133.31 (Ar CH), 133.68, (C4), 133.06 (CH2=CH), 
127.80 (C3, quat.),  118.54 (CH=CH2), 112.63 (Ar C, quat.), 108.72 (Ar C, quat.), 
102.07 (Ar C, quat.), 62.47 (OCH3), 61.16 (OCH3), 34.55 (CH-CH2); IR 
(CH2Cl2): ν 2965, 1708 (C=O), 1586 (C=C), 1376, 1147, 1135, 1076, 966 cm
-1
; 
Calcd. HRMS for C14H12Br2O4Na (M+Na), 424.9000; Found, 424.9013. 































7-Allyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one (Table 4, entry 8): Colourless 
solid, m. p. 135 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.39 (s, C4-H), 6.82 (s, 
C5-H),  6.80 (s, C8-H), 6.06 (s, O-CH2-O), 5.92-5.98 (m, CH2-C=H), 5.19-5.23 
(m, HC=CH2), 3.28 (dq, J1 = 6.80 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C NMR (126 
MHz, CDCl3) δ ppm 162.11 (C=O, quat.), 150.46 (Ar C, quat.), 153.06 (Ar C, 
quat.), 144.90 (Ar C, quat.), 139.40 (C4-H), 134.17 (CH2=CH), 124.81 (C3), 
118.14 (CH=CH2), 113.36 (Ar C, quat.), 104.79 (Ar CH), 102.31 (O-CH2-O), 
98.21(Ar CH), 34.50 (CH-CH2); IR (CH2Cl2): ν 2968, 1708 (C=O), 1593 (C=C), 
1376, 1147, 1135, 1076, 966 cm-1; Calcd. HRMS for C13H11O4 (M+H), 231.0657; 
Found, 231.0663. 
 


























one (Table 4, entry 9): Pale yellow solid, m. p. 67 oC; 1H NMR (500 MHz, 
CDCl3) δ ppm 7.27 (t, J = 0.95 Hz, C4-H), 6.80 (s, C5-H), 5.91-5.99 (m, CH2-
C=H), 5.11-5.17 (m, HC=CH2), 3.21-3.25 (m, 2N-CH2, CH2=CH), 2.88 (t, J = 
6.60 Hz, N-CH2-CH2-CH2), 2.74 (t, J = 6.10 Hz, N-CH2-CH2-CH2), 1.93-1.99 (m, 
2N-CH2-CH2-CH2); 
13C NMR (126 MHz, CDCl3) δ ppm 163.03  (C=O, quat.), 
150.77 (Ar C, quat.), 145.11 (Ar C, quat.), 140.09 (Ar CH), 135.17 (CH2=CH), 
124.37 (C4), 119.59 (C3, quat.), 118.23 (Ar C, quat.), 116.85 (CH=CH2), 108.77 
(Ar C, quat.), 106.60 (Ar C, quat.), 49.96 (N-CH2), 49.59 (N-CH2), 34.25 
(CH=CH2), 27.49 (N-CH2-CH2-CH2), 21.59 (N-CH2-CH2-CH2), 20.69 (N-CH2-
CH2-CH2), 20.38 (N-CH2-CH2-CH2); IR (CH2Cl2): ν 1704 (C=O), 1608 (C=C), 
1566, 1512, 1309,  1164 cm-1; Calcd. HRMS for C18H19O2 (M
+), 281.1416; 
Found, 281.1421. 



























2-Allyl-3H-benzo[f]chromen-3-one (Table 4, entry 10): Pale yellow solid, m. p. 
89 oC; 1H NMR (500 MHz, CDCl3) δ ppm 8.38 (s, C4-H), 8.24 (d, J = 8.35 Hz, 
Ar CH), 7.92 (d, J = 9.00 Hz, Ar CH), 7.90 (d, J = 8.20 Hz, Ar CH), 7.65-7.68 
(m, Ar CH), 7.54-7.57 (m, Ar CH), 7.45 (d, J = 9.00 Hz, Ar CH), 6.02-6.10 (m, 
CH2-C=H), 5.26-5.31 (m, HC=CH2), 3.44 (dq, J1 = 5.70 Hz, J2 = 1.30 Hz, CH2-
C=H); 13C NMR (126 MHz, CDCl3) δ ppm 161.73  (C=O, quat.), 152.52 (Ar C, 
quat.), 134.83 (Ar CH), 133.93 (C4), 132.01 (Ar CH), 130.29 (Ar C, Quat.), 
128.99 (CH2=CH), 128.83 (Ar C, quat.), 127.97 (Ar CH), 127.10 (C3, quat.), 
125.90 (Ar CH), 121.51 (Ar CH), 118.37 (CH=CH2), 116.80 (Ar CH), 113.43 (Ar 
C, quat.) 34.91 (CH-CH2); IR (CH2Cl2): ν 2964, 1712 (C=O), 1586 (C=C), 1376, 
1159, 1135, 1076, 961, 755 cm-1; Calcd. HRMS for C16H13O2 (M+H), 237.0916; 
Found, 237.0921. 





























3-(2-Methylallyl)-2H-chromen-2-one (Table 5, entry 1): Colorless solid, m. p. 
43 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.51(s, C4-H), 7.45-7.50 (m, 2Ar CH), 
7.33 (dd, J1 = 7.70 Hz, J2 = 0.45 Hz, Ar CH), 7.25-7.28 (m, Ar CH), 4.97 (t, J = 
1.65 Hz, CH2-CH(CH3)=CH),  4.85 (q, J = 0.95 Hz, CH(CH3)=CH), 3.22 (s, CH2-
CH(CH3), 1.73 (s, C-CH3); 
13C NMR (126 MHz, CDCl3) δ ppm 161.79 (C=O, 
quat.), 153.22 (Ar C, quat.), 141.94 (C(CH3)=CH2 quat.), 130.78 (Ar CH), 127.43 
(Ar CH), 127.29 (Ar C, quat.),  124.28 (Ar CH), 119.48 (Ar C, quat.) 116.49 (Ar 
CH), 113.73 (C(CH3)=CH2), 38.20 (CH2-C(CH3)), 22.39 (C-CH3); IR (CH2Cl2): ν 
1716 (C=O), 1608 (C=C), 1456, 1421, 1168, 1054, 754 cm-1; Calcd. HRMS for 
C13H13O2 (M+H), 201.0916; Found, 201.0923. 
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7-Methoxy-3-(2-methylallyl)-2H-chromen-2-one (Table 5, entry 2): Colorless 
solid, m. p. 76 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.44 (s, C4-H),  7.33 (d, J 
= 8.35 Hz, C5-H), 6.83 (d, J = 2.5 Hz, C6-H), 6.81-6.82 (m, C8-H), 4.93 (t, J = 
1.65 Hz, CH2-CH(CH3)=CH), 4.86 (q, J = 0.95 Hz, CH(CH3)=CH), 3.85 (s, 
OCH3), 3.23 (s, CH2-CH(CH3), 1.77 (s, C-CH3); 
13C NMR (126 MHz, CDCl3) δ 
ppm 162.12 (C=O), 162.02 (C7, quat.), 154.91 (Ar C, quat.), 142.28 
(C(CH3)=CH2, quat.), 139.62 (C4), 128.17 (Ar CH), 123.69 (Ar C, quat.), 113.38 
(Ar CH), 113.11 (Ar C), 112.42 (Ar CH), 100.48 (C(CH3)=CH2), 55.72 (OCH3), 
38.23 (CH2-C(CH3)), 22.65 (C-CH3); IR (CH2Cl2): ν 1714 (C=O), 1587 (C=C), 
1431, 1164, 1068, 755 cm-1; Calcd. HRMS for C14H14O3Na (M+Na), 253.0841; 
Found, 253.0832. 
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8-tert-Butyl-3-(2-methylallyl)-2H-chromen-2-one (Table 5, entry 3): 
Colourless solid, m. p. 51 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.48 (t, J = 1.10 
Hz, C4-H), 7.46 (dd, J1 = 8.00 Hz, J2 = 1.55 Hz, C5-H), 7.22 (dd, J1 = 7.75 Hz, J2 
= 1.40 Hz, C7-H), 7.18 (dd, J1 = J2 = 7.7 Hz, C6-H), 4.96 (t, J = 1.60 Hz, CH2-
CH(CH3)=CH),  4.86 (q, J = 1.10 Hz, CH(CH3)=CH), 3.28 (s, CH2-CH(CH3), 
1.51 (s, C-CH3); 
13C NMR (126 MHz, CDCl3) δ ppm 161.38 (C=O), 151.89 (Ar 
C, quat.), 142.00 (C(CH3)=CH2 quat.), 140.20 (C4-H), 137.68 (Ar C, quat), 
128.28 (Ar CH), 126.45 (Ar C, quat.), 125.75 (Ar CH), 123.81(Ar CH), 119.89 
(Ar C, quat.) 113.82 (C(CH3)=CH2), 38.00 (CH2-C(CH3)), 34.93 (C(CH3)3, quat.), 
29.86 (C(CH3)3) 22.39 (C-CH3); IR (CH2Cl2): ν 1720 (C=O), 1595 (C=C), 1436, 
1164, 1058, 750 cm-1; Calcd. HRMS for C17H21O2 (M+H), 257.1542; Found, 
257.1543. 
 












(E)-3-(Hex-2-enyl)-6-nitro-2H-chromen-2-one (Table 5, entry 4): Slight 
yellow solid, m. p. 108 oC; 1H NMR (500 MHz, CDCl3) δ ppm 8.39 (d, J = 2.65 
Hz, C5-H), 8.33 (dd, J1 = 9.10 Hz, J2 = 2.65 Hz, C7-H), 7.55 (s, C4-H),  7.43 (d, J 
= 8.95 Hz, C8-H), 5.64-5.70 (m, CH2-CH=CH-), 5.51-5.57 (m, -CH=CH-CH2-
CH3),  3.29 (d, J = 6.80 Hz, -CH2-CH=CH2), 2.04-2.09 (m, =CH-CH2-CH2-), 
1.40-1.47 (m, CH2-CH2-CH3), 0.93 (t, J = 7.25 Hz, CH2-CH3); 
13C NMR (126 
MHz, CDCl3) δ ppm 161.72 (C=O, quat.), 153.07 (C9, quat.), 143.99 (C6, quat.), 
137.04 (C4-H), 135.65 (Ar CH), 131.73 (C3, quat.), 125.42 (CH2-CH=CH-), 
123.92 (CH=CH), 123.11 (Ar CH),  119.62 (Ar C, quat.), 117.55 (Ar CH), 34.66 
(CH2-CH=), 33.47 (=CH-CH2), 22.61 (CH2-CH2-CH3), 13.72 (CH2-CH3); IR 
(CH2Cl2): ν 1731 (C=O), 1635 (C=C), 1598 (C=C), 1529, 1342, 1271, 848, 746 
cm-1; Calcd. HRMS for C15H16NO4 (M+H), 274.1079; Found, 274.1083. 
 
 



























(E)-3-(Hex-2-enyl)-2H-chromen-2-one (Table 5, entry 5): Colorless solid, m. p. 
63 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.48 (s, C4-H),  7.43-7.48 (m, 2Ar 
CH), 7.32 (d, J = 8.35 Hz, C5-H), 7.23-7.28 (m, Ar CH), 5.53-5.66 (CH2-
CH=CH-CH2), 3.26 (d, J = 6.45 Hz, CH2-CH), 2.03-2.08 (m, =CH-CH2-CH2-), 
1.39-1.46 (m, CH2-CH2-CH3), 0.92 (t, J = 7.40 Hz, CH2-CH3); 
13C NMR (126 
MHz, CDCl3) δ ppm 161.72 (C=O, quat.), 153.07 (C9, quat.), 138.49 (C4-H), 
134.51 (Ar CH), 130.57 (Ar CH), 129.03 (C3, quat.), 127.23 (CH2-CH=CH-), 
125.02 (CH=CH), 124.23 (Ar CH)  119.58 (Ar C, quat.), 116.44 (Ar CH), 34.67 
(CH2-CH=), 33.41 (=CH-CH2), 22.48 (CH2-CH2-CH3), 13.71 (CH2-CH3); IR 
(CH2Cl2): ν 1718 (C=O), 1631 (C=C), 1610 (C=C), 1456, 1170, 1051, 754 cm
-1
; 
Calcd. HRMS for C15H16O2Na (M+Na), 251.1048; Found, 251.1057. 
























(E)-3-(But-2-enyl)-2H-chromen-2-one (Table 5, entry 6): Highly viscous pale 
yellow liquid. (6% branched product was obtained). 1H NMR (500 MHz, CDCl3) 
δ ppm 7.51 (s, C4-H),  7.46-7.49 (m, 2Ar CH), 7.32 (d, J = 8.20 Hz, C5-H), 7.26-
7.29 (m, Ar CH), 6.01-6.07 (CH=CH, branched), 5.59-5.71 (-CH=CH-), 5.18-5.25 
(m, =CH2),  3.28 (d, J = 6.50 Hz, CH2-CH), 2.88-2.92 (m, CH2-CH, branched),  
1.76 (dd, J1 = 6.00 Hz, J2 = 0.95 Hz, =CH-CH3), 1.39 (d, J = 6.95 Hz, -CH-CH3, 
branched); 13C NMR (126 MHz, CDCl3) δ ppm 161.78 (C=O, quat.), 153.05 (C9, 
quat.), 138.57 (C4-H), 130.61 (Ar CH), 129.12 (Ar CH), 128.91 (C3, quat.), 
127.25 (Ar CH), 126.11(CH2-CH=CH), 124.28 (CH=CH-CH3), 119.56 (Ar C, 
quat.), 116.45 (Ar CH), 33.39 (CH2-CH=),, 31.01 (CH3-CH, branched), 18.08 
(CH2-CH3); IR (CH2Cl2): ν 1718 (C=O), 1631 (C=C), 1610 (C=C), 1456, 1170, 
1051, 754 cm-1; Calcd. HRMS for C12H13O2Na (M+Na), 223.0735; Found, 
223.0741. 



























3-Cinnamyl-2H-chromen-2-one): Colourless solid, m. p. 110 oC; 1H NMR (500 
MHz, CDCl3) δ ppm 7.56 (s, C5-H), 7.42-7.49 (m, 2Ar CH), 7.40 (s, C4-H),  
7.31-7.35 (m, 3Ar CH), 7.23-7.28 (m, 2Ar CH), 6.58 (d, J = 15.9 Hz, CH=CH-
CH2), 6.34-6.40 (m, CH=CH-CH2),  3.29 (d, J = 7.05 Hz, CH=CH-CH2); 
13C 
NMR (126 MHz, CDCl3) δ ppm 161.83 (C=O, quat.), 153.26 (Ar C, quat.), 
139.15 (C4-H), 137.08 (C3, quat.), 133.49 (CH=CH-Ph), 130.96 (Ar CH), 128.75 
(2Ar CH), 128.40 (C3, quat.), 127.69 (Ar CH), 127.46 (Ar CH), 126.38 (2Ar CH), 
125.32 (Ar CH), 124.51 (CH=CH-Ph), 119.60 (Ar C, quat.), 116.64 (Ar CH), 
33.92 (CH2-CH=); IR (CH2Cl2): ν 1714 (C=O), 1635 (C=C), 1605 (C=C), 1587, 
1529, 1341, 1271, 848, 756 cm-1; Calcd. HRMS for C18H15O2 (M+H), 263.1072; 
Found, 274.1060.   
 




























3-Allyl-2H-pyran-2-one (Compound 32d):20 Colourless liquid, 1H NMR (500 
MHz, CD2Cl2) δ ppm 7.40 (dd, J1 = 5.20 Hz, J2 =  2.00 Hz, C6-H), 7.10 (d, J = 
6.65 Hz, C4-H), 6.17 (dd, J1 = 6.50 Hz, J2 =  5.10 Hz, C5-H), 5.87-5.94 (m, CH2-
C=H), 5.14-5.17 (m, HC=CH2), 3.17 (d, J = 6.80 Hz, CH2-C=H); 
13C NMR (126 
MHz, CD2Cl2) δ ppm 162.78 (C=O, quat.), 150.03 (C6-H), 138.71 (C4-H), 
134.47, (CH=CH2), 128.74 (C3, quat.), 117.77 (CH=CH2),  106.51(C5-H), 34.81 
(CH-CH2); IR (CH2Cl2): ν 2968, 1725 (C=O), 1541 (C=C), 1477, 1147, 1136, 
1046, 957 cm-1; Calcd. HRMS for C8H8O2 (M+), 136.0524; Found, 136.0523 
 
 
                                                



































3-Allyl-4H-chromen-4-one (Compound 33j): Colourless solid, m. p. 44 oC; 1H 
NMR (500 MHz, CDCl3) δ ppm 8.23 (dd, J1 = 8.05 Hz, J2 =  1.75 Hz, C5-H), 
7.75 (t, J = 0.95 Hz, C2-H), 7.63-7.66 (m, Ar CH), 7.43 (dd, J1 = 8.50 Hz, J2 =  
0.65 Hz, Ar CH), 7.37-7.40 (m, Ar CH), 5.92-6.00 (m, CH2-C=H), 5.12-5.20 (m, 
HC=CH2), 3.25 (dq, J1 = 6.60 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C NMR (126 MHz, 
CDCl3) δ ppm 177.50 (C=O), 156.48 (Ar C, quat.) 152.64 (C2), 134.63 
(CH=CH2), 133.43 (Ar CH), 125.93 (Ar CH), 124.94 (Ar CH), 123.78 (C3, quat.), 
123.02 (Ar C, quat.), 118.05 (Ar CH), 117.20 (CH=CH2), 29.71 (CH2-C=H);  IR 
(CH2Cl2): ν 2968, 1702 (C=O), 1531 (C=C), 1477, 1148, 1156, 1046, 951 cm
-1
; 




























(E)-Methyl 3-(3-allyl-2-oxo-2H-chromen-6-yl)acrylate (Compound 34): 
Colourless solid, m. p. 112 oC; 1H NMR (500 MHz, CDCl3) δ ppm 7.69 (d, J = 
15.90 Hz, CH=CH-CO2Me), 7.64 (dd, J1 = 8.65 Hz, J2 = 2.05 Hz, Ar CH), 7.57 
(d, J = 2.05 Hz, Ar CH), 7.50 (s, C4-H), 7.33 (d, J = 8.50 Hz, Ar CH), 6.42 (d, J = 
15.90 Hz, CH=CH-CO2Me), 5.92-6.00 (m, CH2-C=H), 5.22-5.25 (m, HC=CH2), 
3.81 (s, CO2CH3), 3.33 (dq, J1 = 6.75 Hz, J2 = 1.25 Hz, CH2-C=H); 
13C NMR 
(126 MHz, CDCl3) δ ppm 167.15 (CO2Me), 161.06 (O-C=O), 154.08 (Ar C, 
quat.), 143.03 (CH=CH-CO2Me), 138.42 (C4-H),  133.41 (CH2=CH), 130.77 (Ar 
C, quat.), 129.83 (Ar CH), 128.99 (C3, quat.), 127.24 (Ar CH), 119.73 (Ar C, 
quat.), 118.63 (Ar CH) 118.36 (CH=CH2), 117.23 (CH=CH-CO2Me), 51.92 
(COOCH3), 34.57 (CH-CH2); IR (CH2Cl2): ν 1708 (C=O), 1629 (C=C), 1606 
(C=C), 1579 (C=C), 1434, 1168, 1051, 981, 823 cm-1; Calcd. HRMS for C16H15O4 
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3-allyl-2H-thiochromen-2-one (Compound 32e): Pale yellow solid, m. p. 45 oC; 
1H NMR (500 MHz, CDCl3) δ ppm 7.58 (s, C4-H), 7.56-7.57 (m, Ar CH), 7.44 
(m, 2Ar CH), 7.34-7.38 (m, Ar CH), 5.92-6.00 (m, CH=CH2), 5.18-5.22 (m, 
CH=CH2), 3.35 (dq, J1 = 6.80 Hz, J2 = 1.25 Hz, CH2-CH=); 
13C NMR (126 MHz, 
CDCl3) δ ppm 185.74 (C=O, quat.), 141.23 (C4-H), 137.11 (Ar C, quat.), 134.96 
(Ar C, quat.), 134.70 (CH=CH2), 131.17 (Ar CH), 129.10 (Ar CH), 126.79 (C3, 
quat.)  126.45 (CH=CH2), 125.40 (Ar CH), 117.93 (Ar CH), 34.88 (CH2-CH=) ; 
IR (CH2Cl2): ν 2925, 1640 (C=O), 1621 (C=C), 1595, 1454, 1215, 1015, 755 cm
-
1
; Calcd. HRMS for C12H10OS (M+Na), 225.0350; Found, 225.0893.  
S O
32e
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